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Background: Heart failure is likely to be particularly prevalent in the nursing home population, but reliable data
about the prevalence of heart failure in nursing homes are lacking. Therefore the aims of this study are to
investigate (a) the prevalence and management of heart failure in nursing home residents and (b) the relation
between heart failure and care dependency as well as heart failure and quality of life in nursing home residents.
Methods/design: Nursing home residents in the southern part of the Netherlands, aged over 65 years and
receiving long-term somatic or psychogeriatric care will be included in the study. A panel of two cardiologists and
a geriatrician will diagnose heart failure based on data collected from actual clinical examinations (including history,
physical examination, ECG, cardiac markers and echocardiography), patient records and questionnaires. Care
dependency will be measured using the Care Dependency Scale. To measure the quality of life of the participating
residents, the Qualidem will be used for psychogeriatric residents and the SF-12 and VAS for somatic residents.
Conclusion: The study will provide an insight into the actual prevalence and management of heart failure in
nursing home residents as well as their quality of life and care dependency.
Trial registration: Dutch trial register NTR2663Background
Heart failure (HF) is a highly prevalent chronic disease
in older persons. Its prevalence increases with age reach-
ing 15–20% in those aged over 80 years [1]. According
to current guidelines [2], HF is stated as a clinical syn-
drome characterized by the presence of symptoms and
typical signs of HF and objective evidence of a structural
and/or functional abnormality of the heart, usually illu-
strated by echocardiography [2]. Accurate diagnosis of
the presence and aetiology of HF is important given its
crucial influence on therapy. However, signs and symp-
toms of HF in older persons are often obscured, due to
physical limitations or the unreliability of clinical history
due to dementia [3]. In addition, signs of HF, such as fa-
tigue or dyspnoea, are often attributed to the normal
ageing process. Besides, symptoms are often non-specific* Correspondence: m.vandervelden@maastrichtuniversity.nl
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reproduction in any medium, provided the orand can be attributed to other common diseases in older
persons such as venous insufficiency or obesity [4]. The
diagnosis of HF is especially challenging if co-
morbidities are present that share common symptoms of
HF are present such as COPD and venous insufficiency
[5].
This implicates that the diagnosis of HF is particularly
difficult in older persons and nursing home residents. The
latter represent a specific group, involving very frail and
disabled elderly persons with chronic somatic diseases or
progressive dementia, both often being complicated by
co-morbidities [6]. The prevalence of HF in nursing home
residents is estimated to be 20–25% [3,7]. Furthermore,
HF in this specific group is likely to be underdiagnosed,
due to the lack of knowledge regarding adequate diagnosis
and treatment of HF in this population. This counts the
more because nursing home residents are often excluded
from clinical and epidemiological studies.
It is well known that HF is accompanied by a high pa-
tient and economic burden [8]. HF patients are often re-l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Daamen et al. BMC Geriatrics 2012, 12:29 Page 2 of 7
http://www.biomedcentral.com/1471-2318/12/29admitted to hospital, mainly due to periodic episodes of
clinical deterioration [9]. In the Netherlands, as well as
other Western countries cardiovascular diseases (includ-
ing HF) account for the highest hospitalisation rate,
resulting in high financial costs [10,11].
Notwithstanding the fact that survival of HF has
improved in recent decades, once hospitalised for heart
failure, 33% of elderly patients die within the following
year [12]. Women and older persons experience less im-
provement in survival, partly because they often suffer
from HF with a preserved ejection fraction, but also be-
cause they are less likely to receive treatment with B-
blockers and ACE-inhibitors [12,13].
HF also leads to an impaired quality of life [14,15].
The symptoms of HF such as fatigue and dyspnoea re-
sult in increased care dependency which is accompanied
by a decline in health status and quality of life [16].
Therefore, early diagnosis and treatment of HF may pre-
vent the progression of heart failure and lead to im-
provement in symptoms and quality of life [17].
Furthermore, it is known that older persons are less
likely to receive evidence-based treatments for HF [18].
Although ACE- inhibitors have been demonstrated to
benefit HF patients, they remain underused for HF treat-
ment in nursing home settings [19].
The aim of this study is to gain an insight into the
prevalence and management of HF in nursing home
residents and to explore the association between HF,
care dependency and quality of life.
The following research questions will be addressed:
1. What is the prevalence of HF in Dutch nursing
home residents?
2. How is HF currently treated in nursing home
residents both pharmacologically and non-
pharmacologically?
3. What is the association between HF and the care
dependency and quality of life of nursing home
residents?
This article describes the study protocol.
Methods/design
This multicentre study will follow a cross-sectional
design.
Setting
Five healthcare organisations that provide institutional
long-term care in the Southern part of the Netherlands
will participate in the study. These healthcare organisa-
tions have various nursing home facilities for both
chronic somatic and psychogeriatric care. Dutch nursing
home care is provided by teams of registered nurses,
nurse assistants, paramedical professionals and nursinghome physicians, who are employed by the nursing
homes themselves. The care can be characterised as
continuing, long lasting, systematic and multidisciplin-
ary care (CLSM) that is provided via an integrated care
plan after a thorough and integral assessment of the
resident’s problems. Nursing homes also have a geriatric
rehabilitation function for a substantial number of som-
atic residents. The nursing home physician is respon-
sible for all medical care and initiates the different
therapeutic interventions [20].Study population and sample
The study population will consist of nursing home resi-
dents who receive long term care on somatic or psycho-
geriatric wards. Both somatic and psychogeriatric
residents will be eligible when over 65 years of age. Resi-
dents receiving palliative care or admitted for short-term
rehabilitation ( staying < 2 months) will be excluded. The
overall number of nursing home residents at the five
participating healthcare organisations is about 4500.
After excluding the places allocated for rehabilitation
and terminal care about 3500 residents will be available
for recruitment.
A total of 1000 nursing home residents will be
included in the study, with 200 from each participating
organisation. Based on the current segmentation of som-
atic residents (35%) versus psychogeriatric (65%) resi-
dents in Dutch nursing homes, we aim to include 70
somatic and 130 psychogeriatric residents from each
organisation.
In a feasibility study on somatic wards, we found that
about 50% of the approached residents were willing to
participate. Reasons given for not participating included:
they considered themselves too old, or believed that the
investigations would be too burdensome. We also
encountered difficulties, when asking legal representa-
tives to make decisions regarding participation on behalf
of residents. These preliminary findings were in line with
a study conducted by Barnes et al, who also focused on
the recruitment of older people in a HF study, in which
only 30% of the initially identified participants agreed to
participate [21].
Therefore, it will probably be necessary to approach
three times the number of residents per healthcare or-
ganisation in order to recruit 200 residents per site.Sample size calculation
The calculation of sample size was based on an esti-
mated prevalence of HF in nursing home residents of
p= 0.20 with a standard deviation of 0.025 and a confi-
dence level (%) of 95%. No power considerations are
required, because there is no null hypothesis to be
tested. Accordingly, 983 residents should be included in
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selected.
Selection of participants
For practical and logistic reasons, nursing home resi-
dents living in the facilities with the highest number of
residents, will be the first to be recruited per care home
organisation. The residents and/or their legal representa-
tives will receive a letter describing the purpose and con-
tent of the study. Informed consent will be obtained
from the residents themselves or from their legal repre-
sentatives in the case of psychogeriatric residents or resi-
dents with aphasia.
Ethical considerations
The study protocol complies with the Declaration of Hel-
sinki and has been granted approval from the Medical
Ethics Committee of Maastricht University/Academic
Hospital Maastricht. (NL33281.068.10/MEC10-3-074).
The study is registered in the Dutch trial register
(NTR2663).
Study protocol
Training of nursing home physicians
Nursing home physicians (NHP) at each healthcare
organisations (four per site) will participate in the study.
The physicians will receive a refresher course, from a
cardiologist specialising in HF at the Maastricht Univer-
sity Medical Centre, regarding diagnosing HF and per-
forming a structured physical examination. Training will
consist of an introduction about signs and symptoms of
HF followed by bed-side teaching (3 hours) and a session
and lecture about ECG findings in relation to HF (2
hours). The NHP will subsequently visit the University
Medical Centre’s out patient HF clinic to refresh their
knowledge and practise diagnostic skills related to HF (3
hours).
Assessment of heart failure
After training the NHP will start assessing the partici-
pants. During the assessment, the study NHP will per-
form the anamnesis and the physical examination. To
ensure that no prior probability of HF is taken into ac-
count during the history taking and physical examin-
ation, the NHP will not have access to pre-existing
information about the residents, with the exception of
their name and date of birth. Two research nurses and a
NHP/researcher, who will be responsible for gathering
data from the medical records and the questionnaires,
will record the ECG and take blood samples for the
measurement of the NT-pro BNP marker. The ECG will
be interpreted by the same study NHP who executed the
examination. A qualified (fellow) cardiologist will record
the echocardiogram on site, using a mobile echo devicewith recording capabilities. The entire assessment will be
carried out on site in the participating nursing homes.Diagnosis of heart failure
The final diagnosis of HF will be based on all the data
collected and will be made by an expert team of two car-
diologists and a geriatrician using the definition of HF
from the guidelines of the European Society of Cardi-
ology 2008 [2].
To diagnose HF, data will be collected from actual
clinical examinations (including history, physical exam-
ination, ECG, cardiac markers and echocardiogram) and
from the patients’ records (past medical history and
medication).
At the end of the assessment all residents will be cate-
gorized in one of the following groups:
1. No HF
2. HF, no previous history
3. HF, already known (either overt HF with signs and
symptoms or re-compensated HF)Measurements
The data required to answer the research questions are
listed in Table 1.Demographic data and clinical characteristics
Data regarding general and specific resident characteris-
tics will be gathered for all participants. The variables
age, gender, medication, diagnosis on admission and co-
morbidity will be retrieved from the medical records.
The cognitive status of each resident will be measured
using the Mini Mental State Examination (MMSE). This
is a valid test of cognitive function including the areas of
orientation, registration, attention and calculation, recall,
language repetition and complex commands [22].Heart failure
Physical examination and clinical history
The actual history and physical examination will be
recorded on a client record file developed for this study.
In somatic residents the history-related questions will be
answered by the residents themselves; in psychogeriatric
residents these questions will be answered by the nurses
responsible for their daily care and/or the family care-
giver of the resident.Electrocardiogram (ECG)
The clinical assessment will also include a standard 12-
lead ECG, recorded by the research nurse. Abnormal
ECG findings will be identified according to predefined
criteria.





Diagnosis at admission Data from medical record ICD-10
Co-morbidity Data from medical record ICD-10
Medication Medication description Non-cardiac medication
Cognitive impairment MMSE
Heart failure Diagnosis of HF
- History Suffers from:
Dyspnoea on exertion, rest dyspnoea, paroxysmal nocturnal
dyspnoea
Palpitations/irregular heartbeat, leg oedema, orthopnoea, fatigue,
increased weight
Is known to have:
Hypertension, myocardial infarction, cardiac arrhythmia,
angina pectoris (chest pain)/coronary artery disease,
valvular heart disease and/or surgery, CABG, pacemaker,
pre-existing heart failure, history of cardiac surgery
- Physical examination Common signs:
Anaemic, cyanotic, dyspnoeic, obesity, pulse rate, blood pressure
Signs of right heart failure/fluid retention
Neck vein distension, increased jugular venous pressure, right
ventricular pulsations,
pulsations of hepar, hepatojugular reflux, hepatomegaly, ascites,
leg oedema.
Signs of left heart failure/fluid retention
Apex palpable, displacement of the apex, pulmonary rales, signs of
pleural effusion,
3rd heart sound, murmurs, tachycardia, irregular heartbeat/
atrial fibrillation
- ECG Normal ECG, sinus tachycardia, sinusbradycardia, myocardial infarction,
atrial fibrillation, ventricular
arrhythmia, pathological Q’s, AV-block, micro voltage, QRS > 120 ms or
LBTB morphology,
left ventricular hypertrophy, left bundle branch block, right ventricular
hypertrophy
- Cardiac marker NT-pro BNP
- Echocardiography LV ejection fraction, LV function, end-diastolic diameter, end-systolic
diameter, fractional shortening,
left atrial size, left ventricular wall thickness, valvular structure and function,
right ventricular
hypertrophy, right ventricular dysfunction
- Data medical record Blood test, X-thorax
Treatment of heart failure Medication description Cardiac medication
Non pharmacological Sodium restriction, fluid restriction, supplementary nutrition, physical
activity, stop smoking
Cardiovascular risk profile Cardiovascular risk factors Smoking, BMI, diabetes mellitus, hypertension, hypercholesterolaemia
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Table 1 Overview of data collection (Continued)
Pre-existing heart failure Data medical record Specialist that diagnosed heart failure, criteria/ examinations used
for diagnoses
Quality of life Qualidem for psychogeriatric residents
SF-12 for somatic residents
VAS for somatic residents
Care dependency Care dependency scale
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(NT-pro BNP)
A venous blood sample will be taken to determine the
NT-pro BNP concentration. These samples will be ana-
lysed in the clinical chemistry laboratory of the Maas-
tricht University Medical Centre on an Elecsys 2010
(Roche Diagnostics, Mannheim, Germany), using the
NT-pro BNP assay. A normal concentration of NT- pro
BNP <125 pg/ml in an untreated patient has a high
negative predictive value for HF [23].
Echocardiogram
The echocardiogram will be recorded using a Philips
CX50 CompactXtreme Ultrasound System. The echocar-
diogram will provide essential information about the
aetiology and severity of HF.
Complementary information from medical records
Additional information will be obtained from the med-
ical records such as main diagnosis on admission, co-
morbidity, results of recent blood tests or X-thorax (if
available) and currently prescribed medication.
If HF has already been diagnosed, we will search for
information in the medical record about who diagnosed
HF and on which criteria the diagnosis was based.
Current treatment of heart failure
To study the current pharmacological treatment of HF
in nursing homes data will be collected on cardiac medi-
cation prescriptions and data on non-pharmacological
treatment will be extracted from the medical and nurs-
ing records.
Care dependency and quality of life
Care dependency will be assessed using the Care De-
pendency Scale (CDS). The CDS consists of 15 items
measuring human needs on a five-point Likert-type scale
and the score ranges from 15 (completely dependent on
care) to 75 (almost independent of care) [24,25].
Quality of life will be measured using the Short-Form
Health Survey 12 item (SF-12) and the Visual Analogue
Scale (VAS) for somatic residents. The SF-12 is a short
form derived from the SF 36. It has proven validity andit is appropriate for use in studies with a large sample
size and studies focusing on patient-based assessments
[26]. The visual analogue scale (VAS) subjectively mea-
sures the quality of life experienced on a scale from
0–10.
The Qualidem will be used to measure the quality of
life in psychogeriatric residents. This scale contains 37
items divided into 9 subscales. It has sufficient validity
to be used for research in residential care settings
[27,28].Statistical analysis
The data will be analysed using SPSS software PASW
Statistics 17 and will include descriptive frequency distri-
butions for all variables. Differences between groups will
be tested using Student’s T-test or analysis of variance
(ANOVA) for continuous (dependent) variables and the
Chi-square test (cross-table analysis) and/or multivari-
able logistic regression analyses for discrete (dependent)
variables.Discussion
The study will provide insight into the actual prevalence
and management of HF in nursing home residents as
well as their quality of life and care dependency. In order
to improve the care for HF in nursing home residents,
first the accuracy to identify HF in nursing home resi-
dents has to be assessed. HF is likely to be highly preva-
lent in this specific given their advanced age and
prevalence of cardiovascular diseases. Furthermore, HF
is probably underdiagnosed in this group as symptoms
are often not recognised or are misinterpreted. It is also
known that HF is not always treated according to
current guidelines (ESC-guidelines 2008, CBO 2010)
[12,19]. Nursing home residents are often excluded from
epidemiological and clinical studies and therefore the
benefits and adverse effects of medical treatment of HF
in nursing home residents have not been properly
examined.
Eventually, the results of the study will lead to recom-
mendations for improving the diagnostic process and
management of HF in these patients. Moreover the
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care for HF residents.
This study on the prevalence of HF differs from other
studies by the type of approach used to diagnose HF. Of
those studies, reviewed by Daamen and colleagues [3],
most showed a prevalence of about 15–20%, but were
based on retrospective searches of medical records. Only
one study revealed a prevalence of HF of 45% [29] and
in that study HF was diagnosed after a focused clinical
assessment by a geriatrician. This will be the approach
used in our study. On the other hand this may also be a
limitation, as refusal by eligible participants because they
consider the examinations too burdensome may result
in a low number of participants.
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